We believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.
At Intuitive, we work together to advance minimally invasive care and strive to achieve meaningful progress daily with small teams of outstanding people. Innovation is essential to our success. We seek to learn from everyone, copy no one, and challenge the status quo. We approach our work with humility and our colleagues with kindness. Mutual respect, inclusive practices, and diversity of thought are necessary. We believe great work should be rewarded, and we believe in the shared, long-term ownership in Intuitive’s success.
Neocis closed its latest round of funding, led by a prominent dental investor, with participation from Intuitive Ventures and existing partners DFJ Growth, Vivo Capital, Mithril Capital Management, Norwest Venture Partners, and Fred Moll.
Oct 26, 2022 | aegisdentalnetwork.comIntuitive Japan will begin the product launch of SP in the near future.
Sep 29, 2022 | intuitive.com"Cmocro is excited to expand its relationship with Intuitive Surgical and support its visionary leadership in improving human health and surgical outcomes.
Sep 21, 2022 | cmocro.comIn 1999, Intuitive Surgical Inc. launched the da Vinci Surgical Robot System, which received CE market approval in Europe and FDA approval in 2000.
Sep 18, 2022 | perlove.com.cn(Alliance News) - Creo Medical Group PLC on Monday announced a collaboration agreement with Intuitive Surgical Inc as it posted a higher loss for 2021 on cost hikes.
Jan 1, 2022 | shareprices.com[Photo provided to chinadaily.com.cn] Intuitive Surgical Inc, a United States-based robotic surgical system manufacturer, will invest over 700 million yuan ($103.7 million) to build a manufacturing and innovation base in Shanghai to expand access to robotic assisted surgery to more patients in China, said its top executive.
Jan 1, 2022 | gzoutsourcing.cnKēlaHealth, Inc., a San Francisco, CA-based surgical intelligence platform that applies a dynamic cycle of patient-specific predictions, stratified interventions, and outcomes tracking to reduce surgical complications, today announced the closing of a $2.9 million Seed financing and milestone-based $10 million Series A financing led by Santé Ventures and Intuitive Ventures, and inclusive of grant funding from the National Science Foundation Small Business Innovation Research (SBIR) Program.
Oct 28, 2020 | hitconsultant.net